IRIS PubliCatt

Ferrandina, Maria Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.159
NA - Nord America 8.025
AS - Asia 2.578
AF - Africa 70
SA - Sud America 42
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 11
Totale 18.906
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.980
DE - Germania 2.455
SE - Svezia 1.634
CN - Cina 1.370
IT - Italia 912
UA - Ucraina 692
PL - Polonia 618
FR - Francia 498
IE - Irlanda 488
SG - Singapore 458
ID - Indonesia 297
GB - Regno Unito 262
RU - Federazione Russa 210
IN - India 187
FI - Finlandia 174
TR - Turchia 99
BE - Belgio 57
CI - Costa d'Avorio 50
IR - Iran 39
NL - Olanda 35
JP - Giappone 34
CA - Canada 31
HK - Hong Kong 25
CZ - Repubblica Ceca 19
RO - Romania 17
ES - Italia 16
EU - Europa 16
BR - Brasile 15
AT - Austria 14
CH - Svizzera 11
MX - Messico 10
AU - Australia 9
GR - Grecia 9
VN - Vietnam 9
DZ - Algeria 8
HR - Croazia 7
PH - Filippine 7
PK - Pakistan 7
AR - Argentina 6
CL - Cile 6
CO - Colombia 6
MT - Malta 6
AE - Emirati Arabi Uniti 5
NO - Norvegia 5
SA - Arabia Saudita 5
BD - Bangladesh 4
BH - Bahrain 4
IL - Israele 4
MD - Moldavia 4
MY - Malesia 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EC - Ecuador 3
EG - Egitto 3
HU - Ungheria 3
KR - Corea 3
PT - Portogallo 3
RS - Serbia 3
TW - Taiwan 3
A1 - Anonimo 2
BZ - Belize 2
EE - Estonia 2
IQ - Iraq 2
JO - Giordania 2
LK - Sri Lanka 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PA - Panama 2
QA - Qatar 2
TJ - Tagikistan 2
UG - Uganda 2
BG - Bulgaria 1
CM - Camerun 1
DK - Danimarca 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
OM - Oman 1
SC - Seychelles 1
VE - Venezuela 1
Totale 18.906
Salva come PNG Salva come JPEG
Città #
Chandler 1.886
Ashburn 606
Warsaw 570
Dublin 473
Jacksonville 442
San Mateo 408
Wilmington 312
Singapore 301
Jakarta 296
Nanjing 269
Hangzhou 236
New York 233
Ann Arbor 223
Beijing 197
Houston 191
Dearborn 177
Boston 163
Fairfield 158
Nürnberg 149
Moscow 141
Princeton 139
Rome 139
Woodbridge 139
Cattolica 138
Marseille 125
Milan 123
Lawrence 121
Seattle 107
Redwood City 104
Bremen 85
Nanchang 83
Izmir 75
Boardman 62
Cambridge 61
Leawood 60
Lancaster 57
Zhengzhou 56
University Park 54
Brussels 53
Strasbourg 53
Los Angeles 52
Mountain View 51
Abidjan 50
Kraków 47
Norwalk 47
Kunming 46
Detroit 42
Hebei 42
Redmond 41
Shenyang 41
Changsha 39
Jiaxing 38
Augusta 34
Helsinki 32
Andover 31
Chicago 30
Tianjin 30
Pune 29
Fremont 27
Guangzhou 23
Shanghai 22
Munich 20
Hefei 19
San Jose 19
Edinburgh 17
Toronto 17
Palermo 15
Simi Valley 15
Washington 15
London 14
Menlo Park 14
Vienna 14
Busto Arsizio 13
Lanzhou 13
Amsterdam 12
Hong Kong 12
Jinan 12
Phoenixville 12
Ardabil 11
Auburn Hills 11
Millbury 11
San Francisco 11
Frankfurt am Main 10
São Paulo 10
Wuhan 10
Berlin 9
Brno 9
Falls Church 9
Indiana 9
Bologna 8
Kish 8
Naples 8
Perugia 8
Portland 8
Timisoara 8
Bucchianico 7
Lappeenranta 7
Las Vegas 7
Mumbai 7
Sacramento 7
Totale 10.505
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 794
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer 451
Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study 346
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 307
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial 300
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence 247
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 245
Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study 185
I nuovi mezzi di contrasto nello studio delle patologie ginecologiche. Applicazioni diagnostiche e prospettive terapeutiche. 177
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results 173
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. 163
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 162
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 162
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 159
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 149
Adrenomedullin in Ovarian Cancer: Foe In Vitro and Friend In Vivo? 144
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 144
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer. 137
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 135
Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging. 132
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 131
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 129
Sonographic imaging of urinoma 128
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer. 127
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 125
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 121
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 121
Ultrasound contrast examination to discriminate benign and malignant adnexal masses 119
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 119
A case of isolated ovarian recurrence from vulvar carcinoma. 119
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 119
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 114
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 114
Color Doppler sonographic features of a Krukenberg tumor in pregnancy 110
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 110
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 109
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study 105
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 104
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 101
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 101
Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study 100
Ultrasound evaluation of intra-abdominal sites of disease to predict the likelihood of suboptimal cytoreduction in advanced ovarian cancer: a propective study 99
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 98
Preoperative local-regional staging of endometrial cancer: transvaginal sonography versus magnetic resonance imaging 96
Female pelvis 95
Imaging in gynecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor 94
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 93
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 93
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 93
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia) 93
Uterine inversion in association with uterine sarcoma: a case report with MRI findings and review of the literature 92
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 92
Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study. 91
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 91
Neuroendocrine stress response in patients undergoing benign ovarian cyst surgery by laparoscopy, minilaparotomy, and laparotomy 90
Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review 89
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 88
Malignant transformation of Madelung's disease in a patient with a coincidental diagnosis of breast cancer: a case report. 88
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 86
The 'lead vessel': a vascular ultrasound feature of metastasis in the ovaries. 86
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial 85
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 85
Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. The PRICE (PRospective Imaging of CErvical cancer and neoadjuvant treatment) study 2: the role of ultrasound after chemoradiation to assess residual tumor 85
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma 84
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial 83
Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients 83
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 82
Successful multimodal treatment of a breast cancer patient with a recurrence invading the chest wall 82
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 82
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 82
Prognostic significance and clinical relevance of the expression of the HER family of type I receptor tyrosine kinases in human laryngeal squamous cell carcinoma 81
Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. 81
Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literature 81
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 80
ASO Author Reflections: Conization Before Radical Hysterectomy Improves Disease-Free Survival in Early Stage Cervical Cancer 80
Epidermal growth factor levels in human breast cyst fluid 79
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 79
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 79
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 79
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 78
Burkitt's lymphoma of the breast metastatic to the ovary diagnosed during pregnancy 76
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 75
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients 74
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 74
A whole germline BRCA2 gene deletion: How to learn from CNV in silico analysis 74
Epidermal growth factor levels in human breast cyst fluid 73
Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy 73
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 73
Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study database 73
Sonographic features of primary ovarian fibrosarcoma: a report of two cases. 72
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial. 72
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 72
Optimizing treatment in recurrent epithelial ovarian cancer 72
Long-term survival of young endometrial cancer patients desiring fertility preservation treated with hysteroscopic resection followed by hormone therapy (NEMO technique) 72
Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications 70
Prognostic significance and clinical relevance of the expression of the HER family of type I receptor tyrosine kinases in human laryngeal squamous cell carcinoma 69
L'ecografia tridimensionale in ginecologia: indicazioni, limiti e nuovi sviluppi in ginecologia. Working progress. 69
Is the endometrial evaluation routinely required in patients with adult granulosa cell tumors of the ovary? 69
Impact of aromatase inhibitor treatment on vertebral morphology and bone mineral density in postmenopausal women with breast cancer 69
Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors 68
Totale 11.954
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.994
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.216 0 0 167 141 175 266 346 173 252 162 283 251
2020/20212.242 141 199 87 238 299 102 266 64 208 182 363 93
2021/20222.589 285 157 47 257 122 68 46 407 108 192 390 510
2022/20235.190 694 712 411 785 345 631 225 387 628 138 156 78
2023/20242.476 100 729 67 157 74 320 178 87 47 98 319 300
2024/2025636 134 136 366 0 0 0 0 0 0 0 0 0
Totale 20.153